Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
-158.90%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.44%
median of 841 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Phio Pharmaceuticals Corp.
Market Cap
$11.56M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.32M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.12M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
-4489.78%
Market Cap
$12.19M
Gross Margin
36.23%
TTM Avg
36.65%
3Y Avg
39.59%
5Y Avg
41.13%
Market Cap
$10.91M
Gross Margin
59.22%
TTM Avg
55.56%
3Y Avg
55.56%
5Y Avg
55.56%
Market Cap
$10.84M
Gross Margin
89.58%
TTM Avg
88.41%
3Y Avg
-34.57%
5Y Avg
-154.89%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | $11.56M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biofrontera Inc. (BFRI)vs › | $11.43M | 84.45% | 64.39% | 56.15% | 53.94% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 0.00% | 50.00% | 25.00% | -4489.78% |
| BioVie Inc. (BIVI)vs › | $11.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| IRIDEX Corporation (IRIX)vs › | $12.19M | 36.23% | 36.65% | 39.59% | 41.13% |
| Caring Brands, Inc. (CABR)vs › | $10.91M | 59.22% | 55.56% | 55.56% | 55.56% |
| Lantern Pharma Inc. (LTRN)vs › | $12.31M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $10.84M | 89.58% | 88.41% | -34.57% | -154.89% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | 14.12% | 57.06% | 28.53% | 19.02% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | -5085.71% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | -1370.18% |
| 2018-06-30 | -1939.66% |
| 2018-03-31 | -5817.39% |
| 2017-12-31 | -7926.67% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | -14777.78% |
| 2016-03-31 | -12950.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | -6097.06% |
| 2014-12-31 | -11057.14% |
| 2014-09-30 | -9018.75% |
| 2014-06-30 | -9758.33% |
| 2014-03-31 | -4989.66% |
| 2013-12-31 | -4858.62% |
| 2013-09-30 | -1235.87% |
| 2013-06-30 | -439.11% |
| 2013-03-31 | 74.02% |
| 2012-12-31 | -32337.50% |
| 2012-09-30 | -2875.44% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
